Cargando…
Gene therapy following subretinal AAV5 vector delivery is not affected by a previous intravitreal AAV5 vector administration in the partner eye
PURPOSE: In an earlier study we found normal adeno-associated viral vector type 2 (AAV2)-mediated GFP expression after intravitreal injection to one eye of normal C57BL/6J mice. However, GFP expression was very poor in the partner eye of the same mouse if this eye received an intravitreal injection...
Autores principales: | Li, Wensheng, Kong, Fansheng, Li, Xia, Dai, Xufeng, Liu, Xiaoqiang, Zheng, Qinxiang, Wu, Ronghan, Zhou, Xiangtian, Lü, Fan, Chang, Bo, Li, Qiuhong, Hauswirth, William W., Qu, Jia, Pang, Ji-jing |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Molecular Vision
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2633462/ https://www.ncbi.nlm.nih.gov/pubmed/19190735 |
Ejemplares similares
-
Tyrosine capsid-mutant AAV vectors for gene delivery to the canine retina from a subretinal or intravitreal approach
por: Mowat, FM, et al.
Publicado: (2013) -
AAV retinal transduction in a large animal model species: Comparison of a self-complementary AAV2/5 with a single-stranded AAV2/5 vector
por: Petersen-Jones, S.M., et al.
Publicado: (2009) -
Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential
por: Li, Qiuhong, et al.
Publicado: (2008) -
Targeting Photoreceptors via Intravitreal Delivery Using Novel, Capsid-Mutated AAV Vectors
por: Kay, Christine N., et al.
Publicado: (2013) -
T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)